Protien Aggregation - Part A

1. Accurate coarse grained models for protein association and recognition<br>Agustí Emperador<br>2. In silico algorithms and computational methods to predict protein aggregation<br>George Priya Doss Priya Doss C<br>3. Deciphering Protein Aggregation: Insights into Morphology, Contributing Factors, and Diseases<br>Dileep Francis<br>4. Protein Aggregation in Cancer Disease<br>Selvaraj Chandrabose Sr.<br>5. Tau protein aggregation: A therapeutic target for neurodegenerative disease<br>Vijay Kumar Prajapati<br>6. Lipids modulates Tau protein aggregation<br>Subashchandrabose Chinnathambi and Sreeramkumar Selvakumar<br>7. Heat shock proteins regulates Tau protein aggregation in AD<br>Subashchandrabose Chinnathambi<br>8. Alpha-synuclein aggregation in Parkinson disease<br>Edeildo Ferreira da Silva-Júnior<br>9. Understanding the impact of mutations on the structural stability and conformational landscape of LDB3 gene leading to protein aggregation myopathy: A high-performance Molecular Dynamics Simulation Study<br>George Priya Doss Priya Doss C<br>10. Role of protein aggregates in bacteria<br>Ewa Laskowska, Karolina Stojowska-Swędrzyńska and Dorota Kuczyńska-Wiśnik<br>11. Molecular dynamics simulation directed the rational design of inhibitors for aggregation inhibition of SOD1 mutants related to amyotrophic lateral sclerosis (ALS)<br>George Priya Doss Priya Doss C<br>12. Identification of New Non-Toxic Inhibitors of Insulin Fibril Formation and Preservatives for Insulin Preparations<br>Oxana V. Galzitskaya, Sergei Grishin and Alexey Surin<br>13. Exploring therapeutic strategies based on chaperone-mediated disaggregation<br>Edeildo Ferreira da Silva-Júnior<br>14. The Dual Facets of p53 and Its Paralogs: Aggregation and Phase Separation in Cancer Biology<br>Jerson L. Silva<br>15. TBC<br>Ferdinando Fiumara<br>16. Protein aggregation in health and disease: a looking glass of two faces <br>Guilherme A. P. de Oliveira, Jerson L. Silva, Mayra Marques, Dinarte Moreira-Ferreira, Michelle Mota and Guilherme de Andrade<br>17. The aggregation propensity of Amyloid beta and Tau in Alzheimer's disease<br>Subashchandrabose Chinnathambi, Murugappan Kumurappan, Madhura Chandrashekar and Sneha Malik<br>18. The cross-talk between ApoE and Tau protein in Alzheimer's disease<br>Subashchandrabose Chinnathambi, Madhura Chandrashekar and Murugappan Kumurappan<br>19. Tau PET Probes for Alzheimer's Disease detection and their structural characterization<br>Subashchandrabose Chinnathambi, Sneha Malik and Madhura Chandrashekar<br>20. Modifiable Chemical Risk Factors for Tau protein in Alzheimer's Disease<br>Subashchandrabose Chinnathambi, Sneha Malik, Murugappan Kumurappan and Madhura Chandrashekar<br>21. Small molecule mediated therapeutic approaches to target Alzheimer's Disease<br>Subashchandrabose Chinnathambi